Shares of Inovio Pharmaceuticals Inc. INO shed 1.18% to $6.69 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 2 ...

The post INO Stock Earnings: Inovio Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 appeared first on InvestorPlace.

Inovio Pharmaceuticals (INO) shares rallied 19% in the last trading session to close at $11.04. This move can be attributable to notable volume with a higher number of shares being traded than in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Analyst Stephens covers INOVIO Pharmaceuticals highlighting its diverse clinical pipeline and FDA's consideration of INO-3107 Phase 1/2 trials for Accelerated Approval. Potential as the first non ...

In a report issued on July 29, Barclays also upgraded the stock to Buy with a $256.00 price target. See the top stocks recommended by analysts >> Inovio Pharmaceuticals (INO) Oppenheimer analyst ...

Stock Advisor returns as of August 6 ... That includes advancing our lead INO-3107 development program, advancing other promising candidates in our pipeline, and finally, strengthening our ...

In our analysis, these 11 brokerage accounts stand out as the best choices for stock trading, due to their low fees, strong platforms and quality customer support. Many, or all, of the products ...

Earnings Report 1.391 USD Q1 2025 Earnings Release 02/05/2025 Earnings Report 1.219 USD Q2 2025 Earnings Release 05/07/2025 Disney stock has been publicly traded since 1957 when it had its initial ...

The stock's fall snapped a six-day winning streak.